CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Update

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 20,112 shares, an increase of 228.9% from the June 15th total of 6,115 shares. Based on an average daily volume of 348 shares, the days-to-cover ratio is presently 57.8 days.

CellaVision AB (publ) Stock Performance

Shares of OTCMKTS:CLVSF opened at $14.00 on Monday. CellaVision AB has a 52-week low of $13.49 and a 52-week high of $17.30. The business has a 50-day moving average price of $13.56 and a 200-day moving average price of $15.31.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.